Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) is 26.39% higher on its value in year-to-date trading and has touched a low of $1.90 and a high of $9.37 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SNOA stock was last observed hovering at around $2.79 in the last trading session, with the day’s gains setting it 0.61%.
Currently trading at $3.40, the stock is 40.80% and 32.40% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 51.8 million and changing 21.86% at the moment leaves the stock -6.39% off its SMA200. SNOA registered 10.46% gain for a year compared to 6-month loss of 3.66%.
The stock witnessed a 27.82% gain in the last 1 month and extending the period to 3 months gives it a 31.27%, and is 61.14% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 25.12% over the week and 10.40% over the month.
Sonoma Pharmaceuticals Inc (SNOA) has around 172 employees, a market worth around $5.49M and $13.97M in sales. Profit margin for the company is -26.82%. Distance from 52-week low is 78.95% and -63.73% from its 52-week high. The company has generated returns on investments over the last 12 months (-76.51%).
with sales reaching $4.44M over the same period., but quarterly earnings will post 21.48% year-over-year. Quarterly sales are estimated to grow 29.11% in year-over-year returns.
Sonoma Pharmaceuticals Inc (SNOA) Top Institutional Holders
The shares outstanding are 1.62M, and float is at 1.59M with Short Float at 0.97%.
The top institutional shareholder in the company is CITADEL ADVISORS LLC with over 0.2 million shares valued at $41412.0. The investor’s holdings represent 1.2504% of the SNOA Shares outstanding. As of 2024-06-30, the second largest holder is GEODE CAPITAL MANAGEMENT, LLC with 86644.0 shares valued at $18385.0 to account for 0.5551 of the shares outstanding. The other top investors are JANE STREET GROUP, LLC which holds 45295.0 shares representing 0.2902% and valued at over $9611.0, while STATE STREET CORP holds 0.1558 of the shares totaling 24315.0 with a market value of $5160.0.
Sonoma Pharmaceuticals Inc (SNOA) Insider Activity
#####
Still, SEC filings show that on Dec 31 ’24, Gottfurcht Grant (Open Market Purchase) Proposed Sale 17,806 shares at an average price of $2.73 for $48562.0. The insider now directly holds shares of Sonoma Pharmaceuticals Inc (SNOA).
